Home » Topics » BioWorld Science

BioWorld Science
RSS

NMD Pharma cleared to begin phase I/IIa trial of NMD-670 for myasthenia gravis

July 15, 2020

NIAID grant to support development of Versamune-based universal influenza vaccine

July 15, 2020

SIGLEC15 is a prognostic marker in gastric cancer

July 15, 2020

Hackensack Meridian Health collaborates with Merck & Co. to discover COVID-19 treatments

July 15, 2020

Fostamatinib begins clinical evaluation for COVID-19 pneumonia

July 15, 2020

FDA approves Tremfya for active psoriatic arthritis

July 15, 2020

First-in-human study of PD1-Vaxx gains HREC approval to begin in Australia

July 15, 2020

Down syndrome organoids give insights into Alzheimer's disease

July 15, 2020

USP18 found to promote lung cancer growth

July 15, 2020

Phase III BOLD study of odevixibat in biliary atresia enrolls first patient

July 15, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
CC-3 antibody shows antitumoral activity in penile cancer
BioWorld Science
Advanced penile cancer (PeCa) is a rare cancer affecting the genitourinary tract with a 5-year survival rate of about 10% when metastatic. First-line therapies...